Multiple Myeloma Perspective

• Episode 4: CAR T Cells and Immunotherapy in Mantle Cell Lymphoma   Drs Peter Martin and Michael Wang discuss the role of CAR T cells in mantle cell lymphoma, how they are used with respect to bridging therapy, and the surveillance and management of toxicities.
  Medscape, March 30, 2023
• 75 Years: A Look Back on Methotrexate's Fascinating History Dr David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate's importance for immune-mediated inflammatory diseases.
  Medscape Rheumatology, January 25, 2023
• Highlights in Multiple Myeloma From ASH 2022   Dr Joseph Mikhael selects new data on bispecific antibodies, racial and ethnic differences in outcomes, and encouraging results from novel therapies as his multiple myeloma highlights from ASH 2022.
  Medscape, January 03, 2023
• Advances in CAR-T Cell Therapy From ASH 2022   Novel CD7 and CD22 targets and improved outcomes with idecabtagene vicleucel and lisocabtagene maraleucel are among the advances in CAR T-cell therapy from ASH 2022, as selected by Dr Michael Bishop.
  Medscape, December 30, 2022
• S1 Episode 5: Biomarkers and Renal Cell Carcinoma   Drs Sumanta Pal and Rana McKay discuss the use of biomarkers in treating patients with renal cell carcinoma to identify whose disease will recur and who will respond to therapy.
  Medscape, December 08, 2022
• Episode 6: Racial and Ethnic Disparities in Multiple Myeloma   Drs Joseph Mikhael and Brandon Blue reveal the impact of disparities in multiple myeloma and pave a path forward to culturally competent care.
  Medscape, September 06, 2022
• Bias and Other Barriers to HSCT Access Bias, defined as a prejudice in favor of or against a specific treatment on the part of physicians and patients, has not been carefully studied in the realm of cellular therapies.
  MDedge, September 02, 2022
• S1 Episode 1: Frontline Treatment of Renal Cell Carcinoma   Drs Sumanta Pal and Brian Rini discuss frontline treatment of renal cell carcinoma.
  Medscape, September 01, 2022
• Episode 5: Multiple Myeloma Therapies: A Glimpse Into the Future   Drs Joseph Mikhael and Nina Shah discuss the exciting future in multiple myeloma in which bispecifics, CELMoDs, modakafusp, and easily delivered CAR T-cell therapy all may play a role.
  Medscape, August 10, 2022
• Episode 4: Triple-Class Refractory Multiple Myeloma: Approach and Challenges   Joseph Mikhael, MD, and Saad Usmani, MD, discuss options in managing triple-class refractory multiple myeloma including selinexor, belantamab mafodotin, and CAR T-cell therapy.
  Medscape, July 05, 2022
• Multiple Myeloma Highlights From ASCO 2022   Dr Jonathan Kaufman reviews key studies on multiple myeloma presented at ASCO 2022, including the phase 3 DETERMINATION trial, a quadruple induction therapy study, and updated results from MajesTEC-1.
  Medscape, June 28, 2022
• EHA 2022 Read clinically focused news coverage of key developments from EHA 2022
  Medscape Oncology, June 07, 2022
• Bariatric Surgery's 'Dramatic' Effect on Cancer Deaths   If true, weight loss surgery could prevent even more cancers than quitting smoking, says F. Perry Wilson.
  Medscape, June 07, 2022
• Episode 3: Addressing Comorbidities in Multiple Myeloma   Joseph Mikhael, MD, and Ashley Rosko, MD, discuss the role of comorbidities in multiple myeloma and stress the importance of shifting away from the sole use of age-based treatment decisions.
  Medscape, June 02, 2022
• Episode 3: Intermediate-Risk Acute Myeloid Leukemia   Drs Gail Roboz and Pinkal Desai discuss intermediate-risk acute myeloid leukemia.
  Medscape, May 19, 2022
• Episode 2: Frontline Therapy for Multiple Myeloma   Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients.
  Medscape, May 03, 2022
• Episode 1: Screening for Early-Stage Multiple Myeloma   Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it.
  Medscape, May 03, 2022
• 5 Things to Know About New Pneumococcal Vaccine Guidance Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
  CDC Expert Commentary, February 17, 2022
• Advances in Multiple Myeloma From ASH 2021   Bispecific antibodies take center stage in multiple myeloma highlights from ASH 2021, as Dr Amrita Krishnan discusses data on cevostamab, talquetamab, elranatamab, and talquetamab plus daratumumab.
  Medscape, January 06, 2022
• IWMF 2021 Read clinically focused news coverage of key developments from IWMF 2021
  Medscape Oncology, October 29, 2021